Mick Foy has been with the MHRA for more than 35 years, he is a member of the MHRA’s Executive Committee.

He has been Director of Delivery for 2 years following a long career in the agency, primarily in pharmacovigilance, where he was Deputy Director of Patient Safety Monitoring until 2022.

Mick has led the MHRA contribution to the AU3S programme since its inception as part of a global initiative with the Bill and Melinda Gates Foundation.

Mick has previously been Chair of the ICH MedDRA Management Committee and a member of the Uppsala Monitoring Centre Board.